Saturday 17 October 2026
Export PETV’s income statement to Excel — free account
PetVivo Holdings, Inc.
PETV Healthcare Medical Devices
PetVivo Holdings, Inc.’s revenue for fiscal 2026 (year ended March 2026) was $1.1 million, up 0.80% from fiscal 2025. In the quarter to June 2026, revenue grew 13.5%, EPS grew 44.4% and free cash flow grew 40.1%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
0.75
0.01
+1.35%
Follow PETV
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
21.53 | 34.53 | 18.49 | 26.34 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(13.82) | (26.17) | (25.98) | (32.23) | |
P/B ratio |
7.26 | 11.38 | 9.62 | 23.04 | |
Price to Tangible BV |
18.83 | 41.38 | 21.23 | 114.73 | |
EV/Sales |
20.89 | 34.39 | 18.32 | 26.24 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(4.89) | (5.86) | (3.42) | (5.70) | |
EV/FCF |
(4.46) | (5.39) | (3.14) | (5.19) | |
Quick Ratio |
1.00 | 0.41 | 0.65 | 0.16 | |
Current Ratio |
2.00 | 1.40 | 1.24 | 0.72 | |
Net Debt/EBITDA |
0.87 | 0.08 | 0.07 | 0.08 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.33 | 0.30 | 0.18 | 0.25 | |
Operating CF/Net income |
0.70 | 0.63 | 0.26 | 0.56 | |
Capex/Depreciation |
(0.01) | 0.04 | 0.00 | (0.08) | |
Interest Coverage |
(2.19) | — | (1,974.53) | (321.76) | |
Research and Development Expense of Revenue |
86.19% | 112.90% | 192.42% | 69.14% | |
Selling, General and Administrative Expense of Revenue |
667.33% | 703.67% | 657.64% | 473.55% | |
Intangible Assets out of Total Assets |
0.49 | 0.56 | 0.34 | 0.40 | |
Share Based Compensation of Revenue |
230.60% | 198.71% | 187.99% | 136.43% | |
Graham Net Nets |
0.03 | 0.01 | 0.02 | (0.01) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(36.36%) | (33.33%) | (54.29%) | (40.48%) | |
Free Cash Flow Yield |
(21.75%) | (18.48%) | (31.53%) | (19.20%) | |
Revenue per Share |
0.01 | 0.01 | 0.01 | 0.01 | |
Operating CF per Share |
(0.08) | (0.04) | (0.03) | (0.03) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.08) | (0.04) | (0.03) | (0.03) | |
Cash per Share |
0.03 | 0.01 | 0.01 | 0.00 | |
Shareholders Equity per Share |
0.15 | 0.10 | 0.07 | 0.04 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.15 | 0.10 | 0.07 | 0.04 | |
Free Cash Flow |
(2.20) | (1.46) | (0.81) | (0.98) | |
Working Capital |
1.06 | 0.39 | 0.33 | (0.37) | |
Capital Expenditures |
(0.01) | 0.01 | 0.00 | (0.01) | |
Net Current Asset Value |
1.03 | 0.39 | 0.33 | (0.37) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.03 | (0.02) | 0.00 | 0.04 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
0.14 | 0.36 | 2.58 | 0.05 | |
Average Payables |
0.57 | 0.71 | 0.68 | 0.60 | |
Average Inventory |
0.48 | 0.48 | 0.43 | 0.49 | |
Average Assets |
4.22 | 3.74 | 6.46 | 4.78 | |
Average Common Equity |
2.29 | 1.34 | 3.20 | 2.54 |
Columns are period end dates